{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:22Z","timestamp":1791176842498,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.ejca.2009.07.024","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:33:18Z","timestamp":1250670798000},"page":"2714-2721","source":"Crossref","is-referenced-by-count":33,"title":["What\u2019s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination"],"prefix":"10.1016","volume":"45","author":[{"given":"Elsebeth","family":"Lynge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahti","family":"Antilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereo","family":"Segnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2009.07.024_bib1","unstructured":"Arbyn M, Antilla A, Jordan J, et al., editors. European guidelines for quality assurance in cervical cancer screening. Luxembourg: European Commission; 2008."},{"issue":"15","key":"10.1016\/j.ejca.2009.07.024_bib2","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.ejca.2009.07.020","article-title":"Cervical cancer screening policies and coverage in Europe","volume":"45","author":"Anttila","year":"2009","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.024_bib3","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.ejca.2009.07.016","article-title":"The challenges of organising cervical screening programmes in the 15 old member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24S3","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ejca.2009.07.024_bib5","unstructured":"<http:\/\/www-dep.iarc.fr\/nordcan.htm> [accessed 11.07.08]."},{"key":"10.1016\/j.ejca.2009.07.024_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2009.07.024_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/314111a0","article-title":"Structure and transcription of human papillomavirus sequences in cervical carcinoma cells","volume":"314","author":"Schwartz","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2009.07.024_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.2910520513","article-title":"The causal link between human papillomavirus and invasive cervical cancer: a population-based case\u2013control study in Colombia and Spain","volume":"52","author":"Mu\u00f1oz","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.07.024_bib10","unstructured":"International Agency for Research on Cancer. IARC monograph on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol. 64. International Agency for Research on Cancer: Lyon, France; 1995."},{"key":"10.1016\/j.ejca.2009.07.024_bib11","unstructured":"International Agency for Research on Cancer. IARC monograph on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol. 90. International Agency for Research on Cancer: Lyon, France; 2007."},{"issue":"15","key":"10.1016\/j.ejca.2009.07.024_bib12","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical cancer? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ejca.2009.07.024_bib14","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejca.2009.07.024_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ijc.11474","article-title":"Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomised clinical trial","volume":"107","author":"Hogewoning","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.293.6548.659","article-title":"Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes","volume":"293","author":"Anonymous","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.024_bib17","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2009.07.024_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2009.07.024_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.39219.645475.55","article-title":"Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study","volume":"335","author":"Davey","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.024_bib20","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26S","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejca.2009.07.024_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasm","volume":"96","author":"Arbyn","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.07.024_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejca.2006.11.013","article-title":"HPV triage for Low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology","volume":"43","author":"Ronco","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib24","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2009.07.024_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2006.08.053","article-title":"Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomised studies","volume":"104","author":"Koliopoulos","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2009.07.024_bib26","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.024_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolau screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.07.024_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.21611","article-title":"A report on the status of European research on the use of human papillomavirus testing for primary cervical cancer screening","volume":"118","author":"Davies","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejca.2009.07.024_bib30","unstructured":"Bulkmans NWJ, Berkhof J, Rozendall L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007. doi:10,1916\/S0140-6736(07)61450-0."},{"key":"10.1016\/j.ejca.2009.07.024_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2009.07.024_bib32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from a new technologies for cervical cancer randomised controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.07.024_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejca.2007.12.002","article-title":"Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3","volume":"44","author":"Kotaniemi-Talonen","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomised controlled trial comparing human papillomavirus testing alone with conventional cytology as a primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.07.024_bib35","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejca.2009.07.024_bib36","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"Future II Study Group","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejca.2009.07.024_bib37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccinbe against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ejca.2009.07.024_bib38","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.ejca.2009.07.023","article-title":"State of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE\u2217 2008 survey","volume":"45","author":"L\u00e9vy-Bruhl","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.07.024_bib39","first-page":"543","article-title":"Cancer cervicis uteri in situ. Increased perinatal mortality and prematurity after conisation","volume":"106","author":"Lund","year":"1986","journal-title":"Tidskr Nor L\u00e6geforen"},{"key":"10.1016\/j.ejca.2009.07.024_bib40","first-page":"1005","article-title":"Increased risk of preterm birth in women with cervical conization","volume":"81","author":"Kristensen","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2009.07.024_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstectric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2009.07.024_bib42","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.024_bib43","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2009.07.024_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jnci\/djn038","article-title":"Screening for cervical cancer in the era of the HPV vaccine -the urgent need for both new screening guidelines and new biomarkers","volume":"100","author":"Kiviat","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.07.024_bib45","unstructured":"European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in the EU countries. Stockholm: ECDC; 2008."},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2009.07.024_bib46","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2007.11.069","article-title":"Cervical cancer screening following prophylactic human papillomavirus vaccination","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejca.2009.07.024_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1472-6874-8-23","article-title":"New paradigms in cervical cancer prevention: opportunities and risks","volume":"8","author":"Ronco","year":"2008","journal-title":"BMC Women\u2019s Health"},{"key":"10.1016\/j.ejca.2009.07.024_bib48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.07.024_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/EWYGWFRRM8798U5P","article-title":"The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histological lesions found in the NTCC trial","volume":"129","author":"Dalla Palma","year":"2008","journal-title":"Am J Clin Pathol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909005784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909005784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T19:00:02Z","timestamp":1545073202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804909005784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":49,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0959804909005784"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2009.07.024","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}